IDM Pharma, Inc. - Financial and Strategic Analysis Review

IDM Pharma, Inc. - Financial and Strategic Analysis Review

Summary

Global Markets Direct’s “IDM Pharma, Inc. - Financial and Strategic Analysis Review” is an in-depth business, strategic and financial analysis of IDM Pharma, Inc. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

IDM Pharma, Inc. (IDM) is a biopharmaceutical company engaged in developing innovative products that activate the immune system to treat cancer. The company has 5 products in clinical development. The most advanced, mifamurtide (L-MTP-PE), completed a Phase 3 clinical trial in osteosarcoma. Three products are in Phase 2 clinical trials to treat bladder cancer, melanoma, and non small cell lung cancer and one is in Phase 1 for treatment of colorectal cancer. The company carries out its operations in Canada, Europe and United States. It is headquartered in California, the US.

Recent Developments

Jun 24, 2009: Takeda Completes Acquisition Of IDM Pharma

Scope

• Provides key company information for business intelligence needs
• The company’s strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick “one-stop-shop” to understand the company.
• Enhance business/sales activities by understanding customers’ businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors’ weaknesses and target the market opportunities available to them.
• Compare your company’s financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.